STUDY QUESTION: Is the newly discovered cytokine interleukin (IL)-34 expressed at the human fetal-maternal interface in order to influence polarization of monocytes into macrophages of a decidual immunoregulatory phenotype?
STUDY DESIGN, SIZE, DURATION:
The presence of IL-34 at the fetal-maternal interface was evaluated by immunohistochemistry (IHC) and ELISA in placental and decidual tissues as well as in isolated trophoblast cells and decidual stromal cells obtained from first trimester elective surgical terminations of pregnancy (n = 49). IL-34 expression was also assessed in third trimester placental biopsies from women with (n = 21) or without (n = 15) pre-eclampsia. The effect of IL-34 on macrophage polarization was evaluated in an in vitro model of blood monocytes obtained from healthy volunteers (n = 14). In this model, granulocyte macrophage-colony stimulating factor (GM-CSF) serves as a growth factor for M1-like polarization, and M-CSF as a growth factor for M2-like polarization.
PARTICIPANTS/MATERIALS, SETTING, METHODS:
First trimester placental and decidual tissues were obtained from elective pregnancy terminations. Placental biopsies were obtained from women with pre-eclampsia and matched controls in the delivery ward. Polarization of macrophages in vitro was determined by flow-cytometric phenotyping and secretion of cytokines and chemokines in cell-free supernatants by multiplex bead assay.
MAIN RESULTS AND THE ROLE OF CHANCE: Our study shows that IL-34 is produced at the fetal-maternal interface by both placental cyto-and syncytiotrophoblasts and decidual stromal cells. We also show that IL-34, in vitro, is able to polarize blood monocytes into macrophages with a phenotype (CD14 high CD163 + CD209 + ) and cytokine secretion pattern similar to that of decidual macrophages. The IL-34-induced phenotype was similar, but not identical to the phenotype induced by M-CSF, and both IL-34-and M-CSF-induced macrophages were significantly different (P < 0.05-0.0001 depending on marker) from GM-CSF-polarized M1-like macrophages. Our findings suggest that IL-34 is involved in the establishment of the tolerant milieu found at the fetal-maternal interface by skewing polarization of macrophages into a regulatory phenotype.
Introduction
During pregnancy, the maternal immune system needs to be regulated in order to tolerate the presence of the semi-allogeneic fetus (Erlebacher, 2013; Svensson-Arvelund et al., 2013) . This tolerance is mainly established locally in the decidua (the uterine endometrium during pregnancy) by interactions between fetally derived trophoblast cells and maternal leukocytes, and failure to establish and maintain this tolerance is associated with complications of pregnancy, such as preeclampsia and spontaneous miscarriage (Arck and Hecher, 2013) . Macrophages are one of the major leukocyte populations in the decidua , and are implicated in the success of pregnancy by promoting vascular remodeling (Hazan et al., 2010) , clearance of apoptotic cells (Abrahams et al., 2004) and by controlling immune cell activation, for example by limiting T-cell activation and reducing natural killer cell cytotoxicity (Vacca et al., 2010; Sayama et al., 2013) . Decidual macrophages have a characteristic phenotype with high expression of the pattern recognition receptors CD206 and CD209, and in particular, the scavenger receptor CD163, associated with homeostasis and commonly expressed on tissue-resident macrophages (Svensson et al., 2011; . Decidual macrophages also show high expression of MHC class II (HLA-DR) but low expression of co-stimulatory molecules such as CD86 (Heikkinen et al., 2003) . Further, in the absence of inflammation, decidual macrophages show low production of pro-inflammatory cytokines and chemokines, including interleukin (IL)-12, tumor necrosis factor (TNF) and C-X-C motif chemokine (CXCL)10, and high production of anti-inflammatory cytokines and chemokines, such as IL-10, C-C Motif Chemokine Ligand (CCL)2 and CCL18 (Gustafsson et al., 2008; Svensson et al., 2011) .
We have previously shown that macrophage-colony stimulating factor (M-CSF) (Svensson et al., 2011) , for example derived from the fetal placenta , is involved in the regulation of human decidual macrophages and is able to polarize blood monocytes into macrophages that resemble those in the decidua. Mouse studies have also shown that M-CSF influences macrophage density and proliferation, and CCL2-mediated monocyte recruitment to the pregnant uterus. These findings were in part demonstrated by blockade of the colony stimulating factor (CSF)-1 (M-CSF) receptor (Tagliani et al., 2011) . Interestingly, IL-34 is a cytokine that was detected as a second ligand for the M-CSF receptor (Lin et al., 2008) , thus making IL-34 an interesting, additional candidate in the regulation and maintenance of decidual macrophages. To date, IL-34 is known to be involved in the development or maintenance of other macrophage subsets, such as osteoclasts (Gu et al., 2011) , Langerhans cells and microglia (Greter et al., 2012; Wang et al., 2012) . Macrophages cultured in the presence of IL-34 show immunosuppressive properties, for example by inhibiting T-cell proliferation and inducing macrophages with the regulatory marker CD163, similar to M-CSF (Chihara et al., 2010; Foucher et al., 2013) . However, the presence and potential role of IL-34 at the fetal-maternal interface is unknown. We therefore wanted to examine if IL-34 is present in the human decidua and fetal placenta, and whether it is able to induce macrophages of a decidual phenotype. We show that IL-34 is present both at the fetal and maternal side, in trophoblast cells and decidual stromal cells, respectively. Furthermore, IL-34 is able to induce macrophages of a regulatory phenotype, similar to that in decidua, suggesting a role for IL-34 in promoting fetal tolerance and homeostasis in pregnancy.
Materials and Methods

Subjects
For the in vitro experiments, blood monocytes were obtained from 14 non-pregnant healthy women; seven samples from venous blood drawn in heparin-treated tubes and the remaining seven as buffy coats from blood donors. Placental and decidual tissues were obtained from 49 women undergoing elective surgical termination of pregnancy at Linköping University Hospital, Sweden (n = 34) and at the Royal Victoria Infirmary, Newcastle upon Tyne, UK (n = 15). All pregnancies were viable and the gestational age (mean 9 weeks, range 6-13) was determined by crownrump length using ultrasound. Prior to surgery, Misoprostol (Cytotec, Searle) was administrated to all women. Plasma samples from normal pregnancies (n = 83, mean age 30 years, mean gestation age week 35) and pre-eclamptic pregnancies (n = 85, mean age 29 years, mean gestation age week 36), defined as hypertensive proteinuria after week 20, were collected for cytokine analysis at the time of diagnosis for the pre-eclamptic women, and at a regular visit for antenatal care or at admission for elective cesarean section for the control group; see Boij et al. (2012) for details. Placental biopsies used for immunohistochemistry (IHC) were collected post-partum, including healthy normal placentas (n = 15), placentas from early onset (EOP, before week 32) and late onset (LOP) pre-eclampsia (n = 9 and n = 12, respectively). The placentas were collected after elective cesarean section, with the exception of eight cases in the LOP group, of which five were collected after vaginal delivery and three after acute cesarean section. All participants gave their written informed consent. For one participant, who was under the age of 18 years, written informed consent was also obtained from the parents. This study was approved by the regional ethics committee in Linköping, and by the Newcastle and North Tyneside research ethics committee.
Tissues and cells
Placental and decidual tissue
Placental (n = 15) and decidual (n = 12) tissues were rinsed with a saline solution, placed in tubes containing Iscove's modified Dulbecco's medium (IMDM, Gibco-Invitrogen, Paisley, UK), supplemented with L-glutamine (292 mg/ml) (Sigma-Aldrich, St. Louis, MO, USA), sodium bicarbonate (3.024 g/l) (Sigma-Aldrich), penicillin (50 IE/ml), streptomycin (50 μg/ml) (PEST, Gibco-Invitrogen), 100× non-essential amino acids (10 ml/l) (Gibco Invitrogen) and 5% fetal bovine serum (FBS) (PAA Laboratories, Cölbe, Germany). The tissues were kept on ice until preparation. The placental and decidual tissues were placed in a mesh and rinsed with phosphate-buffered saline (PBS, Gibco-Invitrogen). Blood clots were removed and the remaining tissue was cut into smaller pieces, i.e. placental and decidual explants, and seeded into 24-well plates (Costar, Cambridge, MA, USA) with 50-100 μg of tissue/well. For each μg of tissue, 10 μl of Roswell Park Memorial Institute (RPMI) 1640 medium (without L-glutamine, Gibco-Invitrogen) supplemented with 10% FBS and 1% PEST/L-glutamine (Gibco-Invitrogen) was added alone or in combination with 100 ng/ml lipopolysaccharide (LPS, from Escherichia coli serotype O26:B6, Sigma-Aldrich). The tissue explants were incubated at 37°C in a 5% CO 2 atmosphere and after 24 h conditioned medium (CM) was collected, centrifuged at 4°C for 5 min at 500g and stored at −70°C. Placental (n = 5) and decidual (n = 5) tissues (50-100 μg) were also collected and lysed in Tissue Protein Extraction Reagent (T-PER), supplemented with 1% Halt Protease Inhibitor Cocktail (Thermo Scientific, Waltham, MA, USA) for intracellular protein analysis.
Isolation of EVT, CTB and CD10
+ stromal cells Extravillous trophoblast (EVT) and cytotrophoblast (CTB) cells were isolated from placental chorionic villi (n = 10) as previously described . Placental villi were enzymatically digested 3 × 25 min at 37°C in 0.125% trypsin (BD Biosciences, Franklin Lakes, NJ) and 0.5 mg DNase I (Sigma). At the end of each digest, supernatants were removed, combined with newborn calf serum (5%) (Sigma), centrifuged and the cell pellets were resuspended in culture medium. Cell suspensions (digest 1 and 2 combined: EVT, digest 3: CTB) were layered onto a Percoll (Sigma) gradient (10-70% Percoll) and centrifuged for 30 min (1200g, no brake) after which the EVT or CTB cells were collected from the 35-45% Percoll layer. EVT and CTB cells (1 × 10 6 cells/ml) were plated in 24-well plates coated with growth factor-reduced Matrigel (BD Biosciences, Franklin Lakes, NJ) or fibronectin (Sigma-Aldrich), respectively. Cells were cultured for 24 h at 37°C and 5% CO 2 . The CM was then collected, centrifuged and stored at −80°C. The purity of isolated EVT and CTB cells was confirmed to be >97% by immunostaining for cytokeratin 7 (all trophoblast cells) and HLA-G (EVT), as previously described . CD10 + stromal cells from decidual tissues (n = 5) were isolated by positive selection using immunomagnetic beads, as previously described (Pitman et al., 2013) .
Antibodies and cytokines
For a list of antibodies (Abs), see Table I . Recombinant human M-CSF, GM-CSF and IL-34 were purchased from Peprotech (Rocky Hill, NJ, USA).
Annexin V-PE and 7-aminoactinomycin D (7-AAD), used to assess cell viability, were purchased from BD Biosciences.
Isolation of blood CD14 + monocytes
Peripheral blood mononuclear cells (PBMC) from healthy women (n = 14) were obtained by centrifugation on Lymphoprep (Axis-shield, Oslo, Norway) and CD14 + cells were isolated from PBMC by positive selection using magnetic cell sorting (Miltenyi Biotec, Bergisch Gladbach, Germany), as previously described (Svensson et al., 2011) .
Macrophage differentiation and polarization
Macrophages were generated from CD14 + blood monocytes as previously described (Svensson et al., 2011) , and stimulated with 5 ng/ml GM-CSF (n = 10), 50 ng/ml M-CSF (n = 10), 50 or 100 ng/ml IL-34 (n = 13 and n = 9, respectively), or in a combination of M-CSF and IL-34 (25 or 50 ng/ml of each cytokine, n = 8-9) for 6 days. The concentrations were based on previous reports (Svensson et al., 2011 , Foucher et al., 2013 , SvenssonArvelund et al., 2015 , and we also wanted to have similar concentrations when comparing M-CSF and IL-34. The differentiated macrophages were characterized with flow cytometry (see below) or seeded out in 96-well plates at a concentration of 0.5 × 10 6 /ml, and incubated for 24 h at 37°C. After 24 h, cell-free supernatants were collected and stored at −70°C for further use.
IL-34 neutralization
To determine if IL-34 produced by placental tissue is involved in generating decidual-type M2 macrophages, neutralizing IL-34 antibodies were used during the polarization of macrophages with CM from placental explants (n = 6), which was previously shown to induce macrophages of a decidual phenotype . Macrophages were generated with GM-CSF, with or without 12.5% placental explant CM, and neutralizing anti-IL-34 Abs or isotype-matched control added 1 h before. As a positive control, the blocking ability of the IL-34 neutralizing Abs was assessed by exposing macrophages to neutralizing Abs with recombinant IL-34 during the polarization process.
Flow cytometry and gating
Six-color flow cytometry was used to assess the phenotype of the macrophages, as previously described (Svensson et al., 2011) . Data acquisition was carried out on a FACSCanto II (BD Biosciences) using FACSDiva software (version 6.1.2; BD Biosciences). The median fluorescence intensity (MFI) ratio was calculated as the median fluorescence of a specific marker divided by the median fluorescence for the corresponding isotype control in the entire macrophage population. All gating was done using Kaluza software version 1.2 (Beckman Coulter, Marseille, France).
Immunohistochemistry
Sections (4 μm) from formalin-fixed and paraffin-embedded first trimester placental (n = 12) and decidual (n = 9) tissues, as well as from normal term placental (n = 15), EOP placental (n = 9) and LOP placental (n = 12) tissues, were deparaffinized by washing three times with Histoclear (Histolab, Gothenburg, Sweden) and progressively rehydrated from 100% to 50% ethanol and placed in distilled water. The washing steps between incubations were performed with PBS-Tween (0.05%, Medicago, Uppsala, Sweden), followed by a final wash in distilled water. Antigen retrieval was done by microwaving the samples for 20 min in 10 mM Tris-1mM EDTA, pH 9. Primary anti-IL-34 (1:100, clone 1D12), anti-M-CSF (1:25), anti-CD45 (1:50) and anti-CD10 (1:25) mouse monoclonal Abs, diluted in PBS containing 3% normal goat serum (Dako) and 0.1% Triton X-100 (Sigma-Aldrich) were added to the tissue sections and incubated overnight at 4°C. As a negative control for IL-34 staining, a matched isotype control was used. Following additional washing, the tissue sections were incubated together with biotin-conjugated, polyclonal goat anti-mouse secondary Abs (diluted 1:200 in PBS containing 3% normal goat serum and 0.1% Triton X-100). Once again the tissue sections were washed, followed by a 20 min incubation with 3% hydrogen peroxide (Sigma-Aldrich) to block unspecific peroxidase activity. Development of the staining was done using the Vectastain ABC kit and diaminobenzidine (DAB) as substrate (Vector Labs, BioNordika, Sweden). Slides were mounted with ImmunoHistoMount (Sigma-Aldrich). Visualization and photography were performed using a Nikon Eclipse E600 microscope, a Nikon DS-Ri2 camera and Nikon Image Software (NIS) 4.4. For term placental slides, samples were analyzed in a blinded manner, 10 pictures were taken randomized, by following a standardized grid pattern while taking the images. Only areas including villi with a diameter of 40-100 μm were taken into consideration. The eyepiece magnification value was at 10× and the objective magnification was set at 20×. Intensity measurement of DAB staining in the trophoblast layers was performed using ImageJ software. Digitally analyzing the staining intensity gives a value between 0 and 255, where 0 represents the darkest shade and 255 the lightest. Because of this, the intensity of the region of interest was subtracted from 255, resulting in a reciprocal intensity in arbitrary units, which was proportional to the amount of present antigen.
IL-34 ELISA
To investigate if IL-34 is produced by cells at the fetal-maternal interface, CM from EVT cells (n = 10), CTB cells (n = 10), placental (n = 15) and decidual (n = 12) explants, as well as lysates from whole placental (n = 5) and decidual (n = 5) tissues were analyzed with an IL-34 Duo-Set ELISA (R&D Systems, Minneapolis, MN, USA). This ELISA was also used for detecting IL-34 in plasma samples from normal pregnancies (n = 83) and pre-eclamptic pregnancies (n = 85), either EOP (n = 24) or LOP (n = 61). The detection limit was 200 pg/ml and values below the detection limit were given half this value. For the Duo-Set ELISA, high binding half-area 96-well plates (Fisher Scientific, Gothenburg, Sweden) were coated with 2 μg/ml IL-34 monoclonal capture Abs (diluted in carbonate-bicarbonate buffer; pH 9.6) and incubated in a plate shaker for 1 h at room temperature in darkness, followed by an overnight incubation at room temperature in darkness. The plates were then washed in PBS-Tween 0.05% (Medicago) and blocked using a blocking solution (consisting of PBS (Medicago) supplemented with 2% low-fat milk) for 1 h at room temperature on a plate shaker in darkness. After additional washings, the standard curve, diluted in PBS supplemented with 1% BSA (Millipore, IL, USA), samples and controls were added in duplicates, and incubated for 2 h at room temperature on a plate shaker in darkness. Biotinylated detection Abs, diluted in High Performance ELISA Buffer (Sanquin, Amsterdam, The Netherlands), were added to each well at a concentration of 1 μg/ml and incubated for 2 h at room temperature on a plate shaker in darkness. After additional washing, streptavidin-horse radish peroxidase (Sanquin), diluted 1:10 000 in High Performance ELISA Buffer, was added to each well and incubated for 30 min on a plate shaker in darkness. Following incubation, the plate was washed one final time; then, 3,3′,5,5′-tetramethylbenzidine (SigmaAldrich) was added to each well in 10 s intervals and incubated for 30 min on a plate shaker in darkness. To stop the reaction, 1.8 M H 2 SO 4 was added to each well and the plate was immediately read at 450 nm, with correction for 540 nm. In an attempt to detect IL-34 in CM from tissues or cells, two commercial IL-34 kits were used in addition (BioLegend, San Diego, CA) and (R&D Systems). The manufacturer's instructions were followed, with the exception that samples and standards were incubated 1 h at room temperature on a plate shaker and subsequently incubated overnight at 4°C in darkness, to increase sensitivity.
Multiplex bead assay
Multiplex bead assay was used according to the manufacturer's protocol (Millipore) to analyze IL-10 (detection limit 1.5 pg/ml), CCL2 (detection limit 2.7 pg/ml), CXCL10 (detection limit 3.0 pg/ml), TNF (detection limit 0.72 pg/ml) and IL-12p70 (detection limit 2.6 pg/ml) in macrophage supernatants (n = 7). The analyses were performed using the Luminex200 ® IS system (Millipore) and the MasterPlex TM QT 2010 software (MiraiBio, San Bruno, CA, USA). Values below the detection limit were given half the value of the detection limit.
Statistics
Flow cytometry data were analyzed with one-way ANOVA and the Sidak multiple-comparison test (the results and interpretations do not differ when analyzed with non-parametric tests, data not shown) Luminex, and ELISA data were analyzed with Kruskal-Wallis test to determine significance and a Mann-Whitney test as a post-hoc if significance was present, using GraphPad Prism v7 (Graph Pad software Inc. San Diego, CA, USA). A P-value of ≤0.05 was considered statistically significant.
Results
IL-34 is present in first trimester placenta and decidua
To investigate if IL-34 is present at the fetal-maternal interface, we analyzed first trimester placental and decidual tissues by IHC. In the placenta, EVT columns (Fig. 1A) , as well as the outer trophoblast layer of the chorionic villi, consisting of the STB and the underlying CTB cells, were prominently stained for IL-34 (Fig. 1A , B and D) as compared with the negative control (Fig. 1C) . In the decidua, cells morphologically appearing as stromal cells were prominently stained for IL-34 (Fig. 1F , G and K) as compared with the negative control (Fig. 1H) . To confirm the stromal cell phenotype of the IL-34 + cells, we stained sequential slides for CD10 (stromal cells) and CD45 (pan-leukocyte marker), showing that the IL-34 + cells were morphologically similar to CD10 + decidual stromal cells, and differed from CD45-expressing leukocytes ( Fig. 1I and J) . Next, we aimed to determine secretion of IL-34 by measuring in the CM from placental and decidual tissues and cells. However, despite several attempts, including three different ELISAs, we were unable to detect secreted IL-34 in CM from placental and decidual tissues (unstimulated or LPS-stimulated) or from isolated EVT, CTB, CD10 + and CD10
-cells (data not shown). We therefore analyzed lysates of first trimester placenta and decidua with ELISA and were able to detect IL-34 protein in both tissues (Fig. 1M ). These findings are in line with previous observations, in which IL-34 could be measured in lysates of in vitro generated epidermal tissue (Schuster et al., 2014) , but was difficult to detect in cell supernatants (Garceau et al., 2010; Guillou-Guillemette et al., 2014; Schuster et al., 2014) . Interestingly, IL-34 was recently shown to form a complex with M-CSF (Ségaliny et al., 2015) , possibly impeding detection of the secreted IL-34 protein.
We therefore wanted to determine if M-CSF and IL-34 showed a similar expression, and found that this was the case in both placenta ( Fig. 1D and E) and decidua ( Fig. 1K and L) , hence in line with a coexpression of M-CSF and IL-34, which is a prerequisite for a potential complex binding.
IL-34 polarizes macrophages into a regulatory phenotype
To determine the effect of IL-34 on macrophage polarization, blood monocytes from healthy women were cultured in the presence of IL-34 for 6 days and subsequently analyzed for their protein expression of decidual macrophage markers. This protein expression was compared to that of macrophages polarized by M-CSF, representing regulatory M2-like macrophages, and to that of GM-CSF-polarized macrophages, which represent more pro-inflammatory M1-like macrophages, with low protein expression of regulatory markers (Svensson et al., 2011; Ushach and Zlotnik, 2016 ). IL-34 was able to polarize macrophages with a phenotype resembling that of M-CSF-induced macrophages and macrophages found in the decidua, with a higher protein expression of CD14, CD163 and CD209 ( Fig. 2A ) and lower protein expression (at 50 ng/ml IL-34) of CD86, as compared with macrophages induced by the more proinflammatory GM-CSF. In general, a higher concentration of IL-34 was needed to induce protein expression of CD163 and CD209 to the same level as induced by M-CSF. The similar protein expression pattern of IL-34 and M-CSF was in general evident both for proportion of positive cells (% of macrophages) and for the density of protein expression per cell (MFI), although the patterns for CD206, HLA-DR and Intercellular adhesion molecule (ICAM)-3 were mainly reflected by their relative fluorescence intensity protein expression. Although IL-34 induced macrophages similar to M-CSF macrophages, and both M-CSF and IL-34 macrophages differed significantly to the phenotype induced by GM-CSF, some notable differences were observed. IL-34 yielded macrophages with a significantly higher protein expression (MFI or %, or both) of CD14 and HLA-DR, with lower protein expression of CD163, CD209 and CD86, compared with M-CSF macrophages ( Fig. 2A) .
To further elucidate the effects of IL-34, we analyzed secretion of IL-10, TNF, CCL2, CXCL10 and IL-12p70 from polarized macrophages (Figs. 2B and S1). Macrophages polarized by IL-34 and M-CSF showed a lower TNF secretion and tended to have a higher IL-10 secretion (P = 0.053 for the higher IL-34 concentration) compared with macrophages induced by GM-CSF. CCL2 levels were higher in M-CSF-induced, as compared with GM-CSF-induced macrophages, while this was not seen in IL-34-induced macrophages. IL-12p70 was undetectable in all samples, and CXCL10 did not differ across groups (Supplementary Fig. S1 ).
Combining IL-34 and M-CSF shows an M-CSF-dominated phenotype
Since M-CSF and IL-34 bind to the same receptor and have been shown to act in synergy (Ségaliny et al., 2015) , we wanted to investigate their combined effect on macrophage polarization. This was done by culturing blood monocytes in the presence of a combination of either 25 ng/ml or 50 ng/ml M-CSF and IL-34. As seen in Fig. 3A , macrophages cultured with the combination of cytokines generally acquired a phenotype more similar to that of M-CSF, with a lower Representative pictures from first trimester showing staining of IL-34 in (A-C) fetal placenta (n = 12), (F-H) in decidua (n = 9) and (I, J) decidual staining of CD10 (n = 3) and CD45 (n = 3), serial section staining of (D) IL-34 and (E) M-CSF in placenta (n = 3) and (K, L) decidua (n = 3). (C) Isotype matched control stained placenta (n = 3) and (H) isotype matched control stained decidua (n = 3). (J) Whole placental (n = 5) and decidual (n = 5) tissue lysates were analyzed with IL-34 ELISA; medians are shown and the dotted line denotes the detection limit. EVT, extravillous trophoblast cell.
Figure 2 IL-34 induces macrophages with a phenotype similar to that of M-CSF and significantly different from granulocyte macrophage-colony stimulating factor-induced macrophages. (A) Blood monocytes from healthy non-pregnant women were differentiated to macrophages by culturing in the presence of 5 ng/ml granulocyte-macrophage colony stimulating factor (GM-CSF) (n = 10), 50 ng/ml M-CSF (n = 10), 50 or 100 ng/ml IL-34 (n = 13 and n = 9, respectively) for 6 days and the phenotype was assessed by flow cytometry. (B) Levels of secreted cytokines and chemokines were measured in cell-free supernatants using the same culture conditions (n = 7 for all conditions). Flow cytometry data were analyzed with one-way ANOVA and the Sidak multiple-comparison test, cytokine and chemokine data were analyzed with Kruskal-Wallis test and Mann-Whitney. Graphs show the mean and SD (A) and the median (B). *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001. CCL2, C-C Motif Chemokine Ligand-2, MFI, median fluorescence intensity, TNF, tumor necrosis factor. Figure 3 A combination of IL-34 and M-CSF yields macrophages similar to those induced by M-CSF alone. Macrophages were generated by culturing monocytes for 6 days in the presence of 50 ng/ml M-CSF (n = 8), 50 ng/ml IL-34 (n = 8) or in a combination of IL-34 and M-CSF (25 or 50 ng/ml of both cytokines) (n = 9 and n = 8 respectively). (A) The phenotype was analyzed with flow cytometry and statistical differences tested with one-way ANOVA and the Sidak multiple-comparison test. (B) Levels of secreted cytokines and chemokines in cell-free supernatants using the same culture conditions (n = 7) were analyzed by multiplex assay and statistical differences were tested with Kruskal-Wallis and Mann-Whitney tests. Graphs show the mean and SD (A) and the median (B). *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001. protein expression of CD14 and HLA-DR and a higher protein expression of CD209, than that of IL-34-macrophages, suggesting a predominance of M-CSF. Furthermore, the IL-10 and CCL2 secretion induced by the combination of M-CSF and IL-34 mostly resembled that of M-CSF alone (Fig. 3B) . No differences were observed regarding CXCL10 ( Supplementary Fig. S2 ) and TNF production among the different conditions.
IL-34 neutralization during polarization with placental explant CM did not alter the phenotypic characteristics of macrophages
We have previously shown that CM from placental tissue explants was able to polarize macrophages into a phenotype resembling that of decidual macrophages and that M-CSF blockade only partially reversed the decidual macrophage phenotype . Thus, to investigate the possible role of placenta-derived IL-34 in the induction of M2 macrophages, macrophages were cultured with GM-CSF and polarized by the presence of placental explant CM, with and without addition of neutralizing anti-IL-34 Abs. As expected, macrophages cultured in the presence of placental explant CM acquired a more regulatory phenotype compared to GM-CSF alone, with higher expression of CD163, CD14 and CD209, and lower expression of ICAM-3 (data not shown), confirming earlier findings (SvenssonArvelund et al., 2015) . However, neutralization of IL-34 in placental explant CM did not alter the phenotypic characteristics of the macrophages when compared with the isotype controls (data not shown). One possible explanation for the lack of effect would be ineffective blocking by the anti-IL-34 Abs. Therefore, as a positive control of the anti-IL-34 Abs neutralizing ability, monocytes were cultured in the presence of IL-34 and anti-IL-34 Abs. Indeed, after 6 days of culture, no adherent cells were present in wells with anti-IL-34 Abs, showing that the neutralizing Abs blocked the function of No aberrant expression of IL-34 in preeclamptic placentas versus normal placentas Elevated levels of IL-34 have been found in inflammatory diseases, such as rheumatoid arthritis and Sjögren´s syndrome (Hwang et al., 2012; Ciccia et al., 2013; Tian et al., 2013) . Therefore, we wanted to investigate if the expression of IL-34 in the plasma and term placentas from pre-eclamptic women differed from normal pregnant controls, and if a corresponding shift could be seen for M-CSF. No significant differences were observed for IL-34 in the plasma when comparing controls (n = 83, median 100, range 100-1112 pg/ml) with the entire group of pre-eclampsia (n = 85, median 100, range 100-790, P = 0.7). Neither were there any significant differences when subgrouping preeclampsia into EOP (n = 24) and LOP (n = 61), nor when assessing IHC expression in placentas from normal versus pre-eclamptic women (Fig. 4) . Thus, data indicate that IL-34 may not be involved in the pathogenesis of pre-eclampsia. However, increased levels of M-CSF were noted in placentas from pre-eclamptic women compared with control placentas (Fig. 4) .
Discussion
Since its discovery (Lin et al., 2008) , IL-34 has been shown to be involved in the regulation of several tissue-resident macrophage subsets, including osteoclasts (Gu et al., 2011) , Langerhans cells and microglia (Wang et al., 2012) , and has thus emerged as a novel macrophage-regulating factor in addition to the well-known growth and polarizing factors M-CSF and GM-CSF. The present study shows for the first time (to the best of our knowledge) that IL-34 is produced at the human fetal-maternal interface, by both placental CTB and STB, and decidual stromal cells. We also show that IL-34, in vitro, is able to polarize monocytes into macrophages with a phenotype and cytokine secretion pattern similar to that of decidual macrophages . The IL-34-induced phenotype was similar to the phenotype induced by M-CSF, as compared with the M1-like phenotype induced by GM-CSF, although some differences were also observed between M-CSF and IL-34-induced macrophages. Collectively, our findings indicate that IL-34 is involved in the establishment of the tolerant milieu found at the fetal-maternal interface by skewing polarization of macrophages into a regulatory phenotype.
The preferential expression of IL-34 in placental trophoblast cells and in DSC, is in line with previous findings of the non-hematopoietic origin of IL-34, as shown for keratinocytes, neurons (Greter et al., 2012; Wang et al., 2012) and fibroblasts (Boström and Lundberg, 2013) , in both humans and mice. Surprisingly, and in contrast to the expression of M-CSF and the CSF-1R, the mouse uterus and placenta were shown to have minimal expression of IL-34 (Wei et al., 2010) , indicating that IL-34 expression at the fetal-maternal interface differs between species.
Furthermore, we show that IL-34 gives rise to macrophages with a phenotype similar to decidual macrophages and to that of M-CSFinduced macrophages with regards to expression of cell-surface markers and cytokine secretion pattern. This macrophage phenotype has previously been associated with suppressive functions, such as induction of regulatory T-cells and limitation of T-cell activation (Vacca et al., 2010; Sayama et al., 2013) . It has previously been pointed out that despite mainly overlapping effects, M-CSF and IL-34 may have different properties in signaling (Chihara et al., 2010) and non-redundant effects. For example, IL-34, but not M-CSF, is needed for development of microglia and Langerhans cells in mice (Greter et al., 2012; Wang et al., 2012) . Consequently, we found some notable differences between IL-34 and M-CSF, for example a significantly higher expression of HLA-DR, in line with previous findings (Chihara et al., 2010) , as well as a higher expression of CD14, while the expression of CD86, CD163 and CD209 was lower. However, the functional importance of these changes is not known, and we believe that the similarities, as compared with M1 macrophages, have greater impact than the differences. Thus, rather than having unique properties, IL-34 and M-CSF may have complementary effects, as was shown for example in the Csf1op/op mice, where IL-34 was found to rescue defects of bone osteoclasts, tissue macrophages and fertility defects (Wei et al., 2010) .
In addition, our finding of a similar distribution of IL-34 and M-CSF in both DSC and trophoblast cells, may support complementary, rather than non-redundant effects of the two cytokines. In further support of complementary roles in humans was the recent observation that IL-34 and M-CSF may form a bio-active complex (Ségaliny et al., 2015) . When comparing the effects of IL-34 and M-CSF, our data showed that M-CSF may have a predominant role in determining the phenotype, hence suggesting a predominant role of M-CSF on the function of macrophages.
The role of IL-34 in pathological conditions is mostly unknown, although increased serum levels of IL-34 have been reported in inflammatory disorders such as rheumatoid arthritis (Moon et al., 2013; Tian et al., 2013) . We investigated if IL-34 was associated with preeclampsia since this is a disorder associated with increased local and systemic inflammation (Matthiesen et al., 2005; Redman and Sargent, 2010; Boij et al., 2012) . However, we did not find support for this notion, since plasma IL-34 levels did not differ between healthy pregnant women compared to women with early or late onset preeclampsia. The same was true for plasma levels of M-CSF in the same material in a previous study (Boij et al., 2012) . Also, when analyzing trophoblast IL-34 expression by IHC in normal and pre-eclampsia placentas, no difference was found between the groups. M-CSF was increased in placentas from both early and late onset pre-eclampsia, which could be interpreted as an attempt to counteract and downregulate the pro-inflammatory M1 scenario, for example in terms of aberrant GM-CSF expression in pre-eclampsia .
In conclusion, we can for the first time, provide evidence that IL-34 is expressed at the fetal-maternal interface, and influences macrophage polarization towards a regulatory M2 phenotype, suggesting that IL-34 is involved in the maintenance of tolerance during pregnancy.
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